EU reaches deal with Astrazeneca to buy at least 300 million doses of COVID-19 vaccines
|The European Commission announced on Friday that it had reached a deal with pharmaceutical firm AstraZeneca to purchase at least 300 million doses of its potential COVID-19 vaccine, as reported by Reuters.
According to the official statement, the deal also includes an option to purchase 100 million additional doses should the vaccine prove safe and effective.
Market reaction
These comments don't seem to be helping market sentiment improve on Friday. As of writing, the Euro Stoxx 50 was down 1.75% on the day and Germany's DAX 30 was losing 1.2%.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.